Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

230 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Completed

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02101918

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +22 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC

NCT03246659

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • Department of Nuclear Medicine, Innsbruck Medical University Innsbruck, Austria
  • Department of Nuclear Medicine, University Hospital Freiburg Freiburg im Breisgau, Germany
  • Erasmus University Rotterdam Rotterdam, Netherlands
  • Department of Endocrinology, Jagiellonian University Medical College Krakow, Poland
View Trial Details
Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

NCT00625846

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +29 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)

NCT02586350

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
View all 19 locations
View Trial Details
Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details

Related conditions